455.1000 10.00 (2.25%)
NSE Jan 09, 2026 15:31 PM
Volume: 378.4K
 

455.10
2.25%
Angel Broking
Thyrocare Technologies is one of the leading diagnostic chains in India with market share of ~3% amongst organised players. The core business of the company is diagnostic testing (~97.1% of sales as on 9MFY2016) while the company through its wholly owned subsidiary also operates imaging centres. A differentiated model enables higher margi..
Number of FII/FPI investors increased from 99 to 123 in Sep 2025 qtr.
More from Thyrocare Technologies Ltd.
Recommended